Illinois has confirmed its first human case of West Nile virus this year, health officials say. The person, who lives in ...

Senior doctors will be balloted on pay offer The BMA has announced indicative ballots of senior doctors in England, asking whether they are willing to take industrial action over their recent 4% pay ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

Sale prices for the vouchers – which slash FDA review times for a drug – have increased in the past year as biotech funding ...

The pause in Ixchiq use may increase urgency in evaluating these next-generation candidates. What This Means for Other Age Groups. The current FDA and CDC advisory applies only to individuals aged 60 ...

Ixchiq was approved on November 10, 2023, as the world's first approved vaccine for chikungunya, in individuals aged 18 years and older who are at an increased risk of exposure to the virus. 2. In ...

HealthDay News — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has removed all 17 members of the expert panel that makes U.S. vaccine recommendations.. Kennedy made the surprise ...

Vaccination simulations suggest that every 100,000 IXCHIQ doses administered could avert 4,400 (3,800–4,800) CHIKV infections, prevent 0.35 (0.30–0.37) deaths, and save 17 (15–19) DALYs.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

There are no changes in the recommendations for vaccination with IXCHIQ for people of 18 to 64 years of age. The vaccine is currently contraindicated in individuals with immunodeficiency or ...

The Chikungunya virus (CHIKV) is found in the subtropical regions of the Americas, Africa, Southeast Asia , India , and the Pacific Region.

Chikungunya Vaccine (IXCHIQ) Temporarily Paused In People Aged 65 And Over As Precautionary Measure. Date. 2025-06-09 10:11:03. Share on Facebook; Tweet on Twitter ...